Graminex LLC has received Health Canada Approval under the Natura and Non-prescription Health Products Directorate for its PollenBerry Flower Pollen Extract.
Photo © iStockphoto.com/WilshireImages
Graminex LLC (Saginaw, MI) has received Health Canada Approval under the Natura and Non-prescription Health Products Directorate for its PollenBerry Flower Pollen Extract, a proprietary formulation of its G60 Flower Pollen Extract and cranberry powder.
“With the addition of PollenBerry, Graminex now has three finished goods approved by Health Canada’s NNHPD with the associated NPN numbers. We are happy to offer this newest product to our customers,” said Justin E. Ritter, regulatory affairs for Graminex, in a press release.
With this latest NPN license, PolleBerry has been approved for use as a traditional and herbal medicine. Its approved recommended use is to help prevent (recurrent) urinary tract infections, which may increase in frequency after or as a result of menopause in women.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.